Opexa Therapeutics (NASDAQ: OPXA) announced the issuance of four additional key patents covering its broad T-cell immunotherapy platform. The recent ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE